These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9832387)

  • 1. Selective cardiodepressant activity of fluodipine, a fluorenone-1,4-dihydropyridine derivative.
    Budriesi R; Aicardi G; Campana G; Spampinato S; Zaza A; Bisi A; Rampa A; Valenti P; Chiarini A
    Eur J Pharmacol; 1998 Oct; 359(2-3):161-70. PubMed ID: 9832387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment for vascular selectivity of a new dihydropyridine derivative, NB-818.
    Hattori Y; Fukao M; Houzen H; Qi F; Yamada Y; Kanno M
    Eur J Pharmacol; 1996 Apr; 301(1-3):99-106. PubMed ID: 8773452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characteristics of NP-252, a new dihydropyridine slow Ca2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity.
    Shibata S; Satake N; Kodama I; Hester RK; Wang CG; Jino H; Hojo M; Tatsumi H; Gandhi V; Jones DJ
    Eur J Pharmacol; 1991 Oct; 203(3):337-44. PubMed ID: 1773820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T; Kase N; Kita H; Uematsu T
    Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect.
    Masumiya H; Shijuku T; Tanaka H; Shigenobu K
    Eur J Pharmacol; 1998 May; 349(2-3):351-7. PubMed ID: 9671117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline.
    Dong H; Sheng JZ; Lee CM; Wong TM
    Br J Pharmacol; 1993 May; 109(1):113-9. PubMed ID: 8495235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of furyl-dihydropyridine on action potential ventricular myocardium of rabbit in vivo and isolated guinea pig left atrium in vitro].
    Liu DQ; Zhou SS; Zhao DH; Sheng BH
    Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):164-7. PubMed ID: 8352012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of FR34235, a new dihydropyridine slow channel blocker, in isolated rabbit myocardium and aorta.
    Furuta T; Shibata S; Kodama I; Yamada K
    J Cardiovasc Pharmacol; 1983; 5(5):836-41. PubMed ID: 6195473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of aranidipine metabolites with slow binding kinetics to the vasodilating activity of aranidipine.
    Miyoshi K; Miyake H; Ichihara K; Kamei H; Nagasaka M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):119-25. PubMed ID: 9007851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of NPK-1886, a new dihydropyridine compound with calcium entry blocking activity.
    Nagura J; Murayama B; Harada N; Suzuki K; Miyano T; Yajima M; Takeya K
    Jpn J Pharmacol; 1986 Mar; 40(3):399-409. PubMed ID: 3712868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
    Pruneau D; Roy F; Brown NL
    Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+ channel inhibition by a new dihydropyridine derivative, S11568, and its enantiomers S12967 and S12968.
    Randle JC; Lombet A; Nagel N; Abraham C; Aptel H; Peglion JL; Renaud JF
    Eur J Pharmacol; 1990 Nov; 190(1-2):85-96. PubMed ID: 1706275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular properties of LF 2.0254, a new potent vasoselective calcium channel blocker with a slow onset of action.
    Pruneau D; Roy F; Brown NL
    Fundam Clin Pharmacol; 1990; 4(2):223-43. PubMed ID: 2112508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
    Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action.
    Miyoshi K; Kanda A; Miyake H; Ichihara K; Kamei H; Nagasaka M
    Eur J Pharmacol; 1993 Jul; 238(2-3):139-48. PubMed ID: 7691619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
    Nakaya H; Hattori Y; Nakao Y; Kanno M
    Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mibefradil, a selective T-type Ca2+ channel antagonist, on sino-atrial node and ventricular myocardia.
    Masumiya H; Kase J; Tanaka Y; Tanaka H; Shigenobu K
    Res Commun Mol Pathol Pharmacol; 1999; 104(3):321-9. PubMed ID: 10741382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.